<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712061/" ref="ordinalpos=1006&amp;ncbi_uid=6342863&amp;link_uid=PMC3712061" image-link="/pmc/articles/PMC3712061/figure/F7/" class="imagepopup">FIG. 7. From: Hyperglycemia-Induced Protein Kinase C ?2 Activation Induces Diastolic Cardiac Dysfunction in Diabetic Rats by Impairing Caveolin-3 Expression and Akt/eNOS <span class="highlight" style="background-color:">Signaling</span>. </a></div><br /><div class="p4l_captionBody">Schematic depicting hyperglycemia-induced PKCβ2 activation effects upon Cav-3–modulated Akt/eNOS signaling pathway. Cardiomyocyte caveolae are required for hyperglycemia-induced PKCβ2 activation (translocation from cytosol to caveolae membrane). Excessive PKCβ2 activation decreased Cav-3 expression, impairing the Akt/eNOS signaling pathway. Solid arrows depict stimulation, while transverse “T” shape indicates inhibition. PI3K, phosphatidylinositol 3-kinase.</div></div>